您的位置：首页 > 新闻中心 > 社会 > 正文

一闪一闪亮晶晶

今年前7个月厦门新增外贸企业超五千家_我的网站

这个杀手不太冷

A | AI摘要今年前7个月厦门新增外贸企业5057家，同比增长1.1倍，其中民企4755家。

B | 全市存量外贸企业超4.9万家，民企占4.4万家，AEO认证企业达199家，占全省60.1%，外贸主体活力持续增强。

Medicine File photo: VCG
China has granted marketing approval of its first drug for the prevention of acute mountain sickness, filling the long-standing gap in the domestic market where no such medications had been available, Science and Technology Daily reported on Tuesday.
The National Medical Products Administration (NMPA) has approved the marketing of acetazolamide sustained-release capsules, the report said. As the first specialized drug in China indicated for preventing of acute mountain sickness, its approval marks the end of the country's lack of dedicated preventive treatment for altitude illness.
By inhibiting the activity of carbonic anhydrase, acetazolamide promotes the renal excretion of bicarbonate, corrects respiratory alkalosis caused by hypoxia at high altitudes, thereby regulating acid-base balance, optimizing respiratory status, elevating blood oxygen levels, and reducing the risk of onset at the source.
In contrast to health products that only provide auxiliary regulatory effects, this medication has been validated through stringent clinical trials and stands as a specialized drug approved by the NMPA with a clear indication for prevention, said the report.
Led by principal investigator is Luobu Gesang, a deputy dean of the People's Hospital of Xizang Autonomous Region, the clinical trial was designed by his team and has yielded critical evidence to inform prevention strategies for altitude sickness that are specifically adapted to Chinese and Asian populations.
"Previously, although acetazolamide had already been used internationally for the prevention of acute mountain sickness, China had long lacked an NMPA-approved acetazolamide formulation supported by rigorous clinical trials. Furthermore, the existing international formulations were short-acting tablets requiring multiple daily doses, and no drugs with the relevant indication were available on the domestic market for an extended period," said Luobu Gesang.
The sustained-release capsule approved this time not only fills this critical gap but also optimizes the dosage form, providing more reliable and convenient medication protection for the physical health and life safety of people entering high-altitude areas, he added.
Clinical trials showed that, compared with the placebo group, the incidence of acute mountain sickness in the medication group was significantly reduced, with the incidence of moderate-to-severe acute mountain sickness decreasing by 14.6 percent, according to the report.
Related research has been published in the international flagship journal of high-altitude medicine, High Altitude Medicine & Biology.
Global Times
。

C | 厦门网讯（厦门日报记者吴晓菁通讯员陈琪苏晨）厦门海关昨日发布最新数据显示，今年前7个月厦门市新增外贸企业5057家，同比增长1.1倍，其中新增民营企业4755家，同比增长1.2倍。厦门外贸主体呈现加速扩容、提质增效的良好态势，企业深耕国际市场的主动性和竞争力持续增强。

D | “全程网办、极速审批，让我们快速拿到了开拓海外市场的入场券。”厦门致烁科技有限公司相关负责人陈增奎表示，企业近日通过国际贸易“单一窗口”在线提交报关单位备案申请，经海关线上快速审核，仅用数分钟便成功办结手续、获取外贸经营资质，抢抓下半年出口旺季机遇。近年来，厦门海关持续深化“多证合一”改革，加快推进智慧海关建设，持续优化口岸营商环境。

E | 目前，报关单位备案业务已实现全程网办，企业在办理经营主体登记环节，只需勾选海关备案相关选项，海关系统就能自动抓取共享数据、完成智能审核，真正实现企业办事“零跑腿、零成本、高效率”，大幅降低企业制度性交易成本，让企业轻装上阵开拓海外市场。在优化基础政务服务的同时，厦门海关精准实施信用赋能培育，依托“中国海关信用管理服务平台”精准对接专精特新、“新三样”等重点企业需求，建立专项信用培育储备库，常态化开展定制化AEO（经认证的经营者）认证辅导。截至目前，厦门市已有199家企业成功获得AEO认证，占全省AEO企业数量的60.1%。这些企业持有国际贸易信用“绿卡”，可以享受优先通关、降低查验率、跨境信用互认等多项便利，国际竞争力有效提升。厦门海关企业管理和稽查处副处长庄智铉表示，外贸主体规模持续拓展，是厦门外贸产业韧性十足、活力充沛的直观体现。厦门海关数据显示，厦门市存量外贸企业总量已突破4.9万家，其中民营企业4.4万家。民营企业中，生产型企业8265家，非生产型企业35760家。